Can-Fite BioPharma Ltd.
CANF
$1.23
-$0.03-2.38%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 13.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 13.29% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.00% | 13.29% | |||
| SG&A Expenses | 0.00% | -0.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -0.36% | |||
| Operating Income | 0.00% | 1.42% | |||
| Income Before Tax | 0.00% | 0.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 0.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 0.86% | |||
| EBIT | 0.00% | 1.42% | |||
| EBITDA | 0.00% | 1.54% | |||
| EPS Basic | 0.00% | 27.27% | |||
| Normalized Basic EPS | 0.00% | 28.57% | |||
| EPS Diluted | 0.00% | 27.27% | |||
| Normalized Diluted EPS | 0.00% | 28.57% | |||
| Average Basic Shares Outstanding | 0.00% | 38.94% | |||
| Average Diluted Shares Outstanding | 0.00% | 38.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||